17572-85-9

Basic information

• Product Name: 2,6-Diacetoxybicyclo[3,3,0]octane
• Synonyms: 2,6-Diacetoxybicyclo[3,3,0]octane
• CAS NO: 17572-85-9
• Molecular Formula: C₁₂H₁₈O₄
• Molecular Weight: 226.26892
• Mol File: 17572-85-9.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,6-Diacetoxybicyclo[3,3,0]octane(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-Diacetoxybicyclo[3,3,0]octane(17572-85-9)
• EPA Substance Registry System: 2,6-Diacetoxybicyclo[3,3,0]octane(17572-85-9)

Safety Data

• Hazardous Substances Data: 17572-85-9(Hazardous Substances Data)

Usage

Bicyclic organic compound

It has a structure consisting of two interconnected rings, which contributes to its stability and unique chemical properties.

Two acetate groups

These groups (-OAc) are attached to the bicyclo[3,3,0]octane skeleton, influencing its reactivity and compatibility with various chemical reactions.

Bicyclo[3,3,0]octane skeleton

This is the core structure of the compound, a bicyclic ring system, providing the foundation for attaching functional groups and participating in chemical reactions.

Chiral building block

The compound's rigid and symmetric structure allows it to be used as a chiral building block in organic synthesis, which is essential for creating molecules with specific three-dimensional arrangements of atoms.

Diels-Alder cycloadditions

2,6-Diacetoxybicyclo[3,3,0]octane can participate in this type of reaction, a powerful method for forming complex organic molecules with high efficiency.

Potential pharmaceutical applications

The compound can be utilized in the synthesis of biologically active compounds, making it valuable in the development of new drugs and therapies.

Role in chemistry and medicine

2,6-Diacetoxybicyclo[3,3,0]octane plays a crucial role in the development of new molecules with diverse uses, including applications in both the chemical and pharmaceutical industries.

Upstream product

• 1552-12-1 1,5-cis,cis-cyclooctadiene 
• 546-67-8 lead(IV) tetraacetate 
• 64-19-7 acetic acid 
• 5259-72-3 cyclo-octa-1,5-diene 

Downstream Products

• 17572-86-0 endo,endo-cis-bicyclo[3.3.0]octane-2,6-diol 
• 110217-09-9 (+/-)-2-endo-acetoxy-cis-bicyclo<3.3.0>octan-6-endo-ol 
• 36969-85-4 (3aR*,4R*,6aS*)-4-(Hydroxymethyl)hexahydrocyclopentafuran-2-one 
• 17572-86-0 C₈H₁₄O₂ 

Relevant articles and documents

Total Synthesis of (?)-Pepluanol B: Conformational Control of the Eight-Membered-Ring System

The first total synthesis of the Euphorbia diterpenoid pepluanol B in both racemic and enantioenriched form involves 20 steps from a known bicyclic diol. This synthesis features an unprecedented bromo-epoxidation to control the eight-membered-ring conform

NOVEL TRICYCLIC COMPOUNDS AS INHIBITORS OF MUTANT IDH ENZYMES

The present invention is directed to tricyclic compounds of formula (I) which are inhibitors of one or more mutant IDH enzymes: (I); wherein A is -C(R1)= or -N=; and X is selected from the group consisting of: (II-i), (II-ii), (II-iii), and (II-iv). The present invention is also directed to uses of the tricyclic compounds described herein in the potential treatment or prevention of cancers in which one or more mutant IDH enzymes are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such cancers.

Total synthesis and NMR investigations of cylindramide

Cylindramide (1) was built up from three components: a hydroxyornithine derivative 7, a tetrazolylsulfone 8, and a substituted pentalene subunit 9. Derivative 7 was prepared in a six-step reaction sequence involving the Wittig reaction and a Sharpless asy